Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes
Ângela Mesquita, PhD student, University of Bergen, Norway, presents in this MEDtalk from EHA 2024 a new model for predicting treatment efficacy for patients with Myelodysplastic syndromes. This new model may be a better predictor of treatment efficacy as it will integrate the critical role of the microenvironment.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in